Riccardo Leone

Riccardo Leone

Auto-generated profile, based on publicly available information

Riccardo Leone

Computational Neurology Group Ruhr University Bochum Bochum Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Atherosclerosis
Verified
Journal Article
Closed access
ASAlessandra Scoccia
Alessandra Scoccia
GGGuglielmo Gallone
Guglielmo Gallone
ACAlberto Cereda
Alberto Cereda
APAnna Palmisano
Anna Palmisano
DVDavide Vignale
Davide Vignale
MTMarco Toselli
Marco Toselli

1 September 2021 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Closed access
FGFrancesco Giannini
Francesco Giannini
MTMarco Toselli
Marco Toselli
APAnna Palmisano
Anna Palmisano
ACAlberto Cereda
Alberto Cereda
DVDavide Vignale
Davide Vignale
AEAntonio Esposito
Antonio Esposito

1 June 2021 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
Caterina ConteCaterina Conte
Caterina Conte
AEAntonio Esposito
Antonio Esposito
RLRebecca De Lorenzo
Rebecca De Lorenzo
LFLuigi Di Filippo
Luigi Di Filippo
APAnna Palmisano
Anna Palmisano
PRPatrizia Rovere-Querini
Patrizia Rovere-Querini

22 February 2023 in Bioengineering
Verified
Journal Article
Open access
PDF file
Michela DestitoMichela Destito
Michela Destito
Aldo MarzulloAldo Marzullo
Aldo Marzullo
RLRiccardo Leone
Riccardo Leone
Paolo ZaffinoPaolo Zaffino
Paolo Zaffino
SSSara Steffanoni
Sara Steffanoni
MSMaria Francesca Spadea
Maria Francesca Spadea
Primary Central Nervous System Lymphoma (PCNSL) is an aggressive neoplasm with a poor prognosis. Although therapeutic progresses have significantly improved Overall Survival (OS), a number of patients do not respond to HD–MTX-based chemotherapy (15–25%) or experience relapse (25–50%) after an initial response. The reasons underlying this poor response to therapy are unknown. Thus, there is an urgent need to develop improved predictive models for PCNSL. In this study, we investigated whether radiomics features can improve outcome prediction in patients with PCNSL. A total of 80 patients diagnosed with PCNSL were enrolled. A patient sub-group, with complete Magnetic Resonance Imaging (MRI) series, were selected for the stratification analysis. Following radiomics feature extraction and selection, different Machine Learning (ML) models were tested for OS and Progression-free Survival (PFS) prediction. To assess the stability of the selected features, images from 23 patients scanned at three different time points were used to compute the Interclass Correlation Coefficient (ICC) and to evaluate the reproducibility of each feature for both original and normalized images. Features extracted from Z-score normalized images were significantly more stable than those extracted from non-normalized images with an improvement of about 38% on average (p-value < 10−12). The area under the ROC curve (AUC) showed that radiomics-based prediction overcame prediction based on current clinical prognostic factors with an improvement of 23% for OS and 50% for PFS, respectively. These results indicate that radiomics features extracted from normalized MR images can improve prognosis stratification of PCNSL patients and pave the way for further study on its potential role to drive treatment choice.

1 October 2021 in European Journal of Radiology
Verified
Journal Article
Closed access
RLR. Leone
R. Leone
GSG. Sferruzza
G. Sferruzza
TCT. Calimeri
T. Calimeri
SSSara Steffanoni
Sara Steffanoni
GCG.M. Conte
G.M. Conte
NAN. Anzalone
N. Anzalone

3 June 2021 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
Alessandro SticchiAlessandro Sticchi
Alessandro Sticchi
ACAlberto Cereda
Alberto Cereda
MTMarco Toselli
Marco Toselli
AEAntonio Esposito
Antonio Esposito
APAnna Palmisano
Anna Palmisano
FGFrancesco Giannini
Francesco Giannini